Boston Scientific Corporation (LON:0HOY)
97.39
+0.94 (0.97%)
At close: Oct 9, 2025
Boston Scientific Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
18,494 | 16,747 | 14,240 | 12,682 | 11,888 | 9,913 | Upgrade | |
Revenue Growth (YoY) | 21.45% | 17.61% | 12.29% | 6.68% | 19.92% | -7.66% | Upgrade |
Cost of Revenue | 5,868 | 5,257 | 4,345 | 3,956 | 3,711 | 3,465 | Upgrade |
Gross Profit | 12,626 | 11,490 | 9,896 | 8,727 | 8,177 | 6,448 | Upgrade |
Selling, General & Admin | 6,487 | 5,984 | 5,190 | 4,520 | 4,359 | 3,787 | Upgrade |
Depreciation & Amortization Expenses | 874 | 856 | 828 | 803 | 741 | 789 | Upgrade |
Research & Development | 1,835 | 1,615 | 1,414 | 1,323 | 1,204 | 1,143 | Upgrade |
Other Operating Expenses | 123 | 430 | 120 | 433 | 675 | 808 | Upgrade |
Operating Income | 3,148 | 2,603 | 2,343 | 1,649 | 1,199 | -80 | Upgrade |
Interest Expense | -331 | -305 | -265 | -470 | -341 | -361 | Upgrade |
Other Non-Operating Income (Expense) | 184 | -16 | -93 | -38 | 218 | 362 | Upgrade |
Total Non-Operating Income (Expense) | -147 | -321 | -358 | -508 | -123 | 1 | Upgrade |
Pretax Income | 3,000 | 2,282 | 1,985 | 1,141 | 1,076 | -79 | Upgrade |
Provision for Income Taxes | 502 | 436 | 393 | 443 | 36 | 2 | Upgrade |
Net Income | 2,505 | 1,853 | 1,570 | 642 | 985 | -115 | Upgrade |
Minority Interest in Earnings | -8 | -8 | -1 | - | - | - | Upgrade |
Net Income Attributable to Preferred Dividends | - | - | 23 | 55 | 55 | 33 | Upgrade |
Net Income to Common | 2,505 | 1,853 | 1,570 | 642 | 985 | -115 | Upgrade |
Net Income Growth | 36.96% | 18.02% | 144.55% | -34.82% | - | - | Upgrade |
Shares Outstanding (Basic) | 1,476 | 1,472 | 1,453 | 1,431 | 1,422 | 1,417 | Upgrade |
Shares Outstanding (Diluted) | 1,491 | 1,486 | 1,464 | 1,440 | 1,434 | 1,417 | Upgrade |
Shares Change (YoY) | 0.79% | 1.53% | 1.65% | 0.41% | 1.21% | 0.43% | Upgrade |
EPS (Basic) | 1.70 | 1.26 | 1.08 | 0.45 | 0.69 | -0.08 | Upgrade |
EPS (Diluted) | 1.68 | 1.25 | 1.07 | 0.45 | 0.69 | -0.08 | Upgrade |
EPS Growth | 36.59% | 16.82% | 137.78% | -34.78% | - | - | Upgrade |
Free Cash Flow | 3,485 | 2,645 | 1,792 | 938 | 1,316 | 1,132 | Upgrade |
Free Cash Flow Growth | 31.76% | 47.60% | 91.05% | -28.72% | 16.25% | -17.67% | Upgrade |
Free Cash Flow Per Share | 2.34 | 1.78 | 1.22 | 0.65 | 0.92 | 0.80 | Upgrade |
Gross Margin | 68.27% | 68.61% | 69.49% | 68.81% | 68.78% | 65.05% | Upgrade |
Operating Margin | 17.02% | 15.54% | 16.45% | 13.00% | 10.09% | -0.81% | Upgrade |
Profit Margin | 13.51% | 11.02% | 11.18% | 5.50% | 8.75% | -0.82% | Upgrade |
FCF Margin | 18.84% | 15.79% | 12.58% | 7.40% | 11.07% | 11.42% | Upgrade |
EBITDA | 4,463 | 3,872 | 3,539 | 2,785 | 2,292 | 1,043 | Upgrade |
EBITDA Margin | 24.13% | 23.12% | 24.85% | 21.96% | 19.28% | 10.52% | Upgrade |
EBIT | 3,148 | 2,603 | 2,343 | 1,649 | 1,199 | -80 | Upgrade |
EBIT Margin | 17.02% | 15.54% | 16.45% | 13.00% | 10.09% | -0.81% | Upgrade |
Effective Tax Rate | 16.73% | 19.11% | 19.80% | 38.83% | 3.35% | -2.53% | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.